Unlock stock picks and a broker-level newsfeed that powers Wall Street.
1.4050
0.0000
(0.00%)
At close: April 4 at 5:17:04 PM GMT+2
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Bert Junno | Co-Founder & Chairman of the Board | -- | -- | 1966 |
| Mr. Mikael Lindstam | Co-Founder, CEO & Director | -- | -- | 1966 |
| Dr. Luiza Jedlina | Co-Founder & CSO | -- | -- | -- |
| Mr. Ola Skanung | Chief Financial Officer | -- | -- | 1964 |
Aptahem AB (publ)
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 4
Description
Aptahem AB (publ), a biotechnology company, develops and sells aptamer-based pharmaceuticals for the treatment of acute life-threatening conditions. The company's lead products candidate is Apta-1, which is in preclinical stage to prevent the onset of life-threatening organ and tissue damage in sepsis patients. It has collaborations with various academic groups, including Consortium with Orebro University, Seattle Children's Research Institute, and University Health Network. Aptahem AB (publ) was incorporated in 2014 and is based in Malmö, Sweden.
Corporate Governance
Aptahem AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
OND.F Oncopeptides AB (publ)
0.1544
+0.92%
ACTI.ST Active Biotech AB (publ)
0.0724
-5.97%
EGTX.ST Egetis Therapeutics AB (publ)
4.0250
-6.50%
ELIC.ST Elicera Therapeutics AB (publ)
2.9200
-1.02%
ONCO.ST Oncopeptides AB (publ)
1.6660
-2.34%
PHAR Pharming Group N.V.
7.69
+0.79%
DRMA Dermata Therapeutics, Inc.
0.9600
+2.98%
ZEAL.CO Zealand Pharma A/S
426.20
-7.99%
ADTX Aditxt, Inc.
4.7300
-15.23%
GRI GRI Bio, Inc.
1.5100
+4.86%